Offers complete eye care for complex cornea conditions
Contact: Mary Leach
BOSTON, MASS. (Jan. 9, 2015) -- Peter Veldman, M.D., a board-certified ophthalmologist, recently joined the of the Cornea and Refractive Surgery Service at Massachusetts Eye and Ear to offer specialized expertise in lamellar or partial thickness corneal transplantation including Descemet Membrane Endothelial Keratoplasty (DMEK), Descemet Stripping Automated Endothelial Keratoplasty (DSAEK), Deep Anterior Lamellar Keratoplasty (DALK), and Penetrating Keratoplasty (PK).
Dr. Veldman cares for patients at Massachusetts Eye and Ear’s main campus, 243 Charles Street in Boston, and at Massachusetts Eye and Ear, Longwood, 800 Huntington Avenue, Boston.
Dr. Veldman obtained his MD from the Perelman School of Medicine at the University of Pennsylvania, where he received the Jeffrey W. Berger Research in Ophthalmology Award and the Charles A. Oliver Memorial Prize, recognizing the highest academic performance of Penn medical students entering Ophthalmology. He then completed his ophthalmology residency at Harvard Medical School and served as Chief Resident and Director of the Ocular Trauma Service at Mass. Eye and Ear for the 2012 to 2013 academic year. Subsequently, he pursued specialized training in the lamellar (partial thickness) corneal procedures — including DMEK, the thinnest corneal transplant available — as a Cornea Fellow at Devers Eye Institute in Portland, Oregon, under the direction of Drs. Mark Terry and Michael Straiko. As a result of this training, Dr. Veldman is able to offer corneal transplantation options that specifically treat his patients’ diseases without sacrificing otherwise healthy corneal tissues. This approach offers a number of advantages, including faster and better visual recovery as well as decreased risk of graft rejection.
As a clinician scientist, Dr. Veldman has contributed to a number of important research initiatives and publications. In particular, he published a review of the evolving role of DSAEK following the emergence of DMEK as the procedure of choice in endothelial keratoplasty. His research during fellowship focused on the introduction of, and outcomes using, a stromal sided S-stamp in DMEK, which has to date eliminated upside down DMEK graft implantation, a primary cause of graft failure in DMEK. This work was completed in both laboratory and clinical settings through close collaboration with Lions VisionGift, an eye bank located in Portland, OR. Dr. Veldman currently heads a randomized surgical trial at Mass. Eye and Ear comparing suturing techniques in the repair of traumatic corneal lacerations.
To make an appointment with Dr. Veldman, visit this webpage or call 617-573-3202.